Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens
Christina Leah B. Kline, Angelique Schiccitano, Junjia Zhu, Cheryl Beachler, Hassan Sheikh, Harold Harvey, Heath Mackley, Kevin McKenna, Kevin Staveley-O'Carroll, Lisa Poritz, Evangelos Messaris, David Stewart, Jeffrey Sivik, Wafik S. El-Deiry
Dive into the research topics of 'Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens'. Together they form a unique fingerprint.